InnovAge Holding Corp.: updates and filings

INNVNASDAQHealthcare · Services-Health Services

Price

$8.91

November 19, 2026Market cap $1.2B

What Ploutos Investor adds for InnovAge

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from FY2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 76 daysAround Feb 3, 2027 · for Q2 2027

last Nov 3, 2026next Feb 3, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Sep 9, 2026 latest annualNov 3, 2026 latest quarterly
  • Nov 19, 2026Additional annual meeting material
    FormDEFA14A
  • Nov 16, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Nov 5, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 3, 2026Results of operations
    Form8-K
  • Oct 22, 2026Annual report to shareholdersfor the period to Jun 30, 2026
    FormARS
  • Oct 22, 2026Additional annual meeting material
    FormDEFA14A
  • Oct 22, 2026Annual meeting proxy statement
    FormDEF 14A
  • Sep 24, 2026Other material events
    Form8-K
  • Sep 9, 2026Annual reportfor the period to Jun 30, 2026
    Form10-K
  • Sep 8, 2026Results of operations
    Form8-K
  • Aug 4, 2026Filing
    FormEFFECT
  • Jul 31, 2026Shelf registration for future offerings
    FormS-3
  • Jul 17, 2026Filing
    FormDRS
  • May 18, 2026Regulation FD disclosure
    Form8-K
  • May 12, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • May 8, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 5, 2026Results of operations
    Form8-K
  • Mar 17, 2026Regulation FD disclosure
    Form8-K
  • Feb 3, 2026Quarterly reportfor the period to Dec 31, 2025
    Form10-Q
  • Feb 3, 2026Results of operations
    Form8-K
  • Jan 29, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Jan 12, 2026Regulation FD disclosure
    Form8-K
  • Dec 4, 2025Shareholder vote
    Form8-K
  • Nov 4, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 17, 2020.

The full analysis

What do InnovAge's filings show?

The filings are where every one of InnovAge's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.